Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATOMIC: Tumor Cell Vaccination and Cytoxan in High-Risk Neuroblastoma
NCT01192555Phase 2Active, not recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2010
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in neuroblastoma, sponsored by Baylor College of Medicine. Started Sep 2010; status: active, not recruiting.
02
Drugs
cyclophosphamide
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT01192555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192555.